Meetings

Mabswitch CEO Dr. Onakunle will be presenting in the Antibody-Based Cancer Therapies track, discussing groundbreaking advancements in Remote Controlled Antibodies (TUE Nov 5th, 14:20). We’re proud to be part of this inspiring gathering, pushing forward the boundaries of cancer treatment.

Meet Mabswitch CEO and Co-founder Dr. Yemi Onakunle at our booth in the Start-Up Zone at the Festival of Biologics in San Diego in April. Learn about the newest developments on switchable antibody technology, as we also present a poster (No. 101, poster session April 16th at 6:10pm in the Read more